Microsoft Word-26751875-file00

Department of Pharmacology (C.M.N., K.A.J., C.D.W., C.K.J., Z.X., Q.L., A.L.R., J.E.M., T.D.P., A.T., J.E.A., R.W., C.W.L., P.J.C.); Department of Chemistry (C.W.L.), Vanderbilt Program in Drug Discovery (C.M.N., K.A.J., C.D.W., C.K.J., Z.X., Q.L., A.L.R., J.E.M., A.T., R.W., C.W.L., P.J.C.); Vanderbilt Institute for Chemical Biology (C.D.W., E.D., T.N., C.A.A., M.B.W., C.W.L., P.J.C.); Vanderbilt University, Nashville, TN 37232. These authors contributed equally to this work (C.M.N., K.A.J.). Molecular Pharmacology Fast Forward. Published on July 29, 2008 as doi:10.1124/mol.108.049551

[1]  Kari A. Johnson,et al.  A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors , 2008, Molecular Pharmacology.

[2]  P. Jeffrey Conn,et al.  N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) Acts through a Novel Site as a Positive Allosteric Modulator of Group 1 Metabotropic Glutamate Receptors , 2008, Molecular Pharmacology.

[3]  M. Amalric,et al.  Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists. , 2007, Journal of medicinal chemistry.

[4]  P. Conn,et al.  A Novel Family of Potent Negative Allosteric Modulators of Group II Metabotropic Glutamate Receptors , 2007, Journal of Pharmacology and Experimental Therapeutics.

[5]  M. Amalric,et al.  Targeting Group III Metabotropic Glutamate Receptors Produces Complex Behavioral Effects in Rodent Models of Parkinson's Disease , 2007, The Journal of Neuroscience.

[6]  A. Newman,et al.  Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[7]  Andrzej Pilc,et al.  The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats , 2007, Neuroscience.

[8]  A. Dilella,et al.  Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist. , 2007, Journal of medicinal chemistry.

[9]  J. Lacaille,et al.  Compartmentalized Ca2+ Channel Regulation at Divergent Mossy-Fiber Release Sites Underlies Target Cell-Dependent Plasticity , 2006, Neuron.

[10]  J. Bockaert,et al.  MacMARCKS interacts with the metabotropic glutamate receptor type 7 and modulates G protein‐mediated constitutive inhibition of calcium channels , 2006, Journal of neurochemistry.

[11]  P. Conn,et al.  A Novel Class of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Interact with a Site Distinct from That of Negative Allosteric Modulators , 2006, Molecular Pharmacology.

[12]  F. Nicoletti,et al.  Pharmacological Activation of mGlu4 Metabotropic Glutamate Receptors Reduces Nigrostriatal Degeneration in Mice Treated with 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine , 2006, The Journal of Neuroscience.

[13]  A. Faden,et al.  Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. , 2006, CNS drug reviews.

[14]  P. Jeffrey Conn,et al.  Metabotropic glutamate receptors in the basal ganglia motor circuit , 2005, Nature Reviews Neuroscience.

[15]  P. Conn,et al.  New therapeutic frontiers for metabotropic glutamate receptors. , 2005, Current topics in medicinal chemistry.

[16]  S. Ikeda,et al.  Coupling of Metabotropic Glutamate Receptor 8 to N-Type Ca2+ Channels in Rat Sympathetic Neurons , 2005, Molecular Pharmacology.

[17]  C. Lindsley,et al.  A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models , 2005, Journal of Pharmacology and Experimental Therapeutics.

[18]  Liliana Garcia,et al.  High-frequency Stimulation in Parkinson's Disease: More or Less? , 2022 .

[19]  P Jeffrey Conn,et al.  A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain , 2004, Journal of Pharmacology and Experimental Therapeutics.

[20]  S. Duty,et al.  Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine‐treated rat , 2004, British journal of pharmacology.

[21]  I. Vranesic,et al.  (−)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection , 2003, Neuropharmacology.

[22]  A. Dilella,et al.  Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P Jeffrey Conn,et al.  Group III Metabotropic Glutamate Receptor-Mediated Modulation of the Striatopallidal Synapse , 2003, The Journal of Neuroscience.

[24]  J. M. Mathiesen,et al.  Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB‐1893 and MPEP , 2003, British journal of pharmacology.

[25]  P. Ornstein,et al.  Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl)glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  J. Elguero,et al.  Novel (E)‐ and (Z)‐2‐Styrylchromones from (E, E)‐2′‐Hydroxycinnamylideneacetophenones – Xanthones from Daylight Photooxidative Cyclization of (E)‐2‐Styrylchromones , 1998 .

[27]  J. Kemp,et al.  Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.

[28]  Atsuko Fukunaga,et al.  A novel class of antagonists for metabotropic glutamate receptors, 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylates , 1996 .

[29]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[30]  G. Westbrook,et al.  Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. , 1997, Molecular pharmacology.

[31]  B. Conklin,et al.  Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. , 1993, Nature.